GlassScriptPhysician profile
Peter G Gerbino
NPI 1437221736
$2,846.25
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $121 · 2021: $1,785 · 2022: $31.97 · 2023: $199 · 2024: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,272.78 | 2019-2021 | |
| Pacira Therapeutics, INC. | $271.42 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $200.31 | 2019 | |
| Next Science LLC | $180.18 | 2019-2021 | |
| Depuy Synthes Sales INC. | $141.67 | 2019-2024 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $131.85 | 2023-2024 | Zilretta, Iovera, Exparel |
| Bioventus LLC | $95.24 | 2019-2023 | Supartz Fx Sodium Hyaluronate |
| Stryker Corporation | $91.93 | 2020 | |
| Heron Therapeutics, INC. | $79.94 | 2021 | |
| Abbott Laboratories | $69.34 | 2021 | |
| Fidia Pharma USA INC. | $61.43 | 2023-2024 | Hymovis, Triluron |
| Sanofi-Aventis U.S. LLC | $37.31 | 2019-2020 | |
| Radius Health, INC. | $37.29 | 2019-2020 | |
| Orthofix Medical, INC. | $31.97 | 2022 | |
| Vericel Corporation | $31.62 | 2023 | Maci |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28.09 | 2021 | |
| Covidien LP | $26.32 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.51 | 2023 | |
| Avanos Medical | $19.77 | 2023 | Trivisc Sodium Hyaluronate |
| Endo Pharmaceuticals INC. | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Gerbino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.